Banks such as Goldman Sachs (GS) and Citigroup (C) have launched an EUR 7.45B, or $8.1B, debt sale to finance Clayton Dubilier & Rice’s purchase of a stake in Sanofi’s (SNY) consumer health division Opella, Eleanor Duncan of Bloomberg reports. The sale includes EUR 5.45B-equivalent in euro and dollar denominated leveraged loans. Lenders are also marketing EUR 2B-equivalent in bonds. Additionally, a revolving credit facility of EUR 1.2B will be a part of the Sanofi package, bringing the debt total to EUR 8.65B.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GS:
- Autodesk in proxy fight, General Mills reports mixed Q3: Morning Buzz
- Goldman Sachs Stock (NYSE:GS) Slides as Wall Street Rings Alarm Bells over Expected M&A Rebound due to Tariff Uncertainty
- Tesla upgraded, Etsy initiated: Wall Street’s top analyst calls
- Oppenheimer downgrades Goldman Sachs to Perform on delayed M&A rebound
- Goldman Sachs downgraded to Perform from Outperform at Oppenheimer
Questions or Comments about the article? Write to editor@tipranks.com